B. Riley Raises Price Target on Hyperfine to $1.60 From $1.30, Keeps Buy Rating

B. Riley has increased its price target for Hyperfine, Inc. (NASDAQ: HYPR) to $1.60 from $1.30, while maintaining a Buy rating on the stock. This adjustment follows recent company news, including Hyperfine’s Q4 2025 earnings call and a new loan and security agreement. Hyperfine, a health technology company, develops and markets the portable Swoop Portable Magnetic Resonance Imaging System.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin